Cristina Amaral
Ferreira, 4050313, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
The impact of cannabigerol exposure on human endometrial stromal cells decidualization.
Journal: Toxicology
Published: March 12, 2026
Cutting-edge design approaches for steroidal aromatase inhibitors: new horizons for hormone-dependent cancer.
Journal: Expert opinion on drug discovery
Published: December 19, 2025
Effects of cannabidiol, cannabichromene, cannabidivarin, cannabigerol and cannabinol in endometrial cells: Implications for endocrine and senescence modulation.
Journal: Reproductive toxicology (Elmsford, N.Y.)
Published: April 21, 2025
Cannabinol improves exemestane efficacy in estrogen receptor-positive breast cancer models: a comparative study with cannabidiol.
Journal: European journal of pharmacology
Published: February 24, 2025
Impact of minor cannabinoids on key pharmacological targets of estrogen receptor-positive breast cancer.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: February 03, 2025
New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment.
Journal: Cancers
Published: November 27, 2024
Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 17, 2024
Cannabidivarin and cannabigerol induce unfolded protein response and angiogenesis dysregulation in placental trophoblast HTR-8/SVneo cells.
Journal: Archives of toxicology
Published: February 23, 2024
Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies.
Journal: Biochemical pharmacology
Published: December 28, 2023
In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment.
Journal: Molecules (Basel, Switzerland)
Published: April 24, 2023
Effects of a combination of cannabidiol and delta-9-tetrahydrocannabinol on key biological functions of HTR-8/SVneo extravillous trophoblast cells.
Journal: Toxicology
Published: April 10, 2023
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors.
Journal: Cancers
Published: February 14, 2023
Last Updated: 09/26/2026